Efficacy of Intestinal Decontamination in Patients Colonized by Carbapenem-resistant Klebsiella Pneumoniae and Colistin
NCT02604849 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 44
Last updated 2015-11-13
Summary
The identification of all cases (44 patients) was carried out from the database of microbiology, University Hospital Reina Sofía and the University Hospital of Jerez. For the identification of controls, in case of neutropenic patients, all colonized patients that were included during the study period did not receive any decolonitation treatment; in case of non-neutropenic patients it was studied a paired control by the presence of risk factors that indicated the beginning of decolonitation treatment.
Conditions
- Patients Colonized by Klebsiella Pneumoniae.
Interventions
- DRUG
-
Neomycin
- DRUG
-
Streptomycin
- DRUG
-
Gentamicins
Sponsors & Collaborators
-
Maimónides Biomedical Research Institute of Córdoba
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-07-31
- Primary Completion
- 2015-07-31
- Completion
- 2015-11-30
More Related Trials
-
Efficacy of a Short-term Sequential Therapy in Non-complicated Catheter Related Bacteremia by Methicillin- Susceptible S.Aureus.
NCT01875263 ·Status: TERMINATED ·Phase: PHASE3
-
Pharmacokinetics of Colistin in Critically Ill Patients With Extracorporeal Membrane Oxygenation
NCT05542446 ·Status: TERMINATED ·Phase: PHASE4
-
Efficacy and Mortality of a Loading Dose of Colistin in Critical Ill Patients
NCT02117986 ·Status: UNKNOWN ·Phase: PHASE4
-
Impact of Treatment With Colistin on Mortality Bacteremia Multiresistant Acinetobacter Baumannii Sensitive Colistin in Patients Critical
NCT02573064 ·Status: COMPLETED
-
Colistin Monotherapy vs Colsitin-fosfomycine in CRAB Infection
NCT06570850 ·Status: RECRUITING ·Phase: PHASE4
-
Antistaphylococcal Betalactam and Emergence of Resistance
NCT05939479 ·Status: COMPLETED
-
Efficacy and Safety of Colistin for Therapy of Infections Caused by ESBL Producing K.Pneumoniae or E.Coli
NCT00300560 ·Status: UNKNOWN ·Phase: PHASE3
-
Evaluation of Pharmacokinetic and Pharmacodynamic Properties of Intravenous Colistimethate Sodium
NCT02288429 ·Status: COMPLETED
-
Optimizing Dosing of Colistin for Infections Resistant to All Other Antibiotics, Approved NIH Protocol Dated 12.06.07(DMID Protocol #07-0036)
NCT00235690 ·Status: COMPLETED ·Phase: NA
-
Optimization Dose Study on Pharmacokinetics and Pharmacodynamics of Colistin in Critically Ill Patients
NCT02408185 ·Status: COMPLETED ·Phase: PHASE1
-
Incidence and Risk Factors for Developing Infections in Patients Colonized by CP-KPC
NCT05492539 ·Status: UNKNOWN
-
Evaluation of the Non-inferiority of Cefoxitin Versus Imipenem/Cilastatin in the Treatment of Urinary Tract Infections Caused by ESBL-producing Escherichia Coli
NCT02474706 ·Status: TERMINATED ·Phase: PHASE4
-
Clinical and Microbiological Outcomes of Infections Due to Carbapenem-Resistant Gram-Negative Bacteria
NCT01041716 ·Status: COMPLETED
-
Treatment Algorithm to Reduce the Use of Vancomycin in Adults With Blood Stream Infection
NCT01191840 ·Status: COMPLETED ·Phase: PHASE2
-
A Post-Marketing Study to Assess the Efficacy and Safety of Intravenous Polymyxin B and Colistin Methanesulfonate in Patients With Carbapenem-Resistant Gram-Negative Bacterial Infection
NCT06966284 ·Status: RECRUITING
-
Predictors of Rates of Resistant Gram-Negative Bacteria
NCT01075009 ·Status: COMPLETED
-
Cefazolin Versus Antistaphylococcal Penicillins for Methicillin Susceptible Staphylococcus Aureus Bacteremia
NCT07186894 ·Status: ACTIVE_NOT_RECRUITING
-
Efficacy of Colistin Monotherapy Versus Colistin Plus Minocycline for Carbapenem-Resistant A. Baumannii Infection
NCT05586815 ·Status: UNKNOWN ·Phase: PHASE4
-
Colistin Versus Colistin Plus Fosfomycin for Infections Caused by MDR Acinetobacter Baumannii
NCT01297894 ·Status: UNKNOWN ·Phase: PHASE3
-
Efficacy and Safety of 7 Versus 14 Days of Antibiotic Treatment for Pseudomonas Aeruginosa Bacteraemia
NCT05210439 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
SDD for Eradicating CRKP Carriage
NCT01761487 ·Status: UNKNOWN ·Phase: PHASE4
-
Trial for the Treatment of Extensively Drug-Resistant Gram-negative Bacilli (OVERCOME)
NCT01597973 ·Status: COMPLETED ·Phase: PHASE3
-
Imipenem/Cilastatin/Relebactam (IMI/REL) in Treatment of CRE Infections
NCT04785924 ·Status: WITHDRAWN ·Phase: PHASE4
-
Double Carbapenem as Rescue Strategy for the Treatment of Carbapenemase-Producing Klebsiella Pneumoniae Infections
NCT03094494 ·Status: COMPLETED
-
Microbiologic Effect of Selective Decontamination of the Digestive Tract With Colistin, Gentamicin and Nystatin
NCT00250133 ·Status: TERMINATED